Rowland Mayor, MD
Orthopaedic Surgery · Hamden, CTNPI 1073591053
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,073 of the $2,417 with a category attached, or 85.8%. It is spread thinly across 12 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $635 and has fallen 50.2% since, to $317 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in CT, where the typical reported total is $2,417.
Across 38 payments — averaging $63.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$406
- Vericel Corporation$374
- Pacira Therapeutics, Inc.$353
- Smith+Nephew$347
- Hikma Pharmaceuticals USA$344
- Pacira Pharmaceuticals Incorporated$230
- plus $363 from 6 others
What the payments were for
- Consulting fees$34414%
- Food & beverage$2,07386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $406 |
| Vericel Corporation | 3 | $374 |
| Pacira Therapeutics, Inc. | 7 | $353 |
| Smith+Nephew | 5 | $347 |
| Hikma Pharmaceuticals USA | 1 | $344 |
| Pacira Pharmaceuticals Incorporated | 4 | $230 |
| Davol Inc. | 1 | $159 |
| Ferring Pharmaceuticals Inc. | 4 | $76 |
| Zimmer Biomet | 1 | $57 |
| Amgen | 2 | $28 |
| Stryker | 1 | $27 |
| Bioventus LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$374
- Zilretta$373
- COMBOGESIC IV$344
- REAL INTELLIGENCE$149
- Iovera$125
How this compares
$2,417 in reported general payments places this provider in the 50th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 78 | $1,656 |
| Pregabalin | 38 | $444 |
| Oxycodone Hcl | 66 | $355 |
| Meloxicam | 173 | $327 |
| Tramadol Hcl | 31 | $117 |
| Ibuprofen | 16 | $100 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $89 |
| Amoxicillin | 19 | $87 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hamden
- Glenn RussoHamden$41K
- Logan PetitHamden$26K
- Peter WhangNew Haven$1.8M
- Paul SethiGreenwich$1.5M
- James YueShelton$1.3M
- Robert DeveneyDanbury$907K
- James PaceFarmington$721K
- Isaac MossFarmington$676K
- David FrumbergNew Haven$288K
- John KeggiMiddlebury$264K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.